Source author record

Hubertus Van Dam

Hubertus Van Dam appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

2works
5topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2020arXiv

Chimbuko: A Workflow-Level Scalable Performance Trace Analysis Tool

Because of the limits input/output systems currently impose on high-performance computing systems, a new generation of workflows that include online data reduction and analysis is emerging. Diagnosing their performance requires sophisticated performance analysis capabilities due to the complexity of execution patterns and underlying hardware, and no tool could handle the voluminous performance trace data needed to detect potential problems. This work introduces Chimbuko, a performance analysis framework that provides real-time, distributed, in situ anomaly detection. Data volumes are reduced for human-level processing without losing necessary details. Chimbuko supports online performance monitoring via a visualization module that presents the overall workflow anomaly distribution, call stacks, and timelines. Chimbuko also supports the capture and reduction of performance provenance. To the best of our knowledge, Chimbuko is the first online, distributed, and scalable workflow-level performance trace analysis framework, and we demonstrate the tool's usefulness on Oak Ridge National Laboratory's Summit system.

preprint2020arXiv

Targeting SARS-CoV-2 with AI- and HPC-enabled Lead Generation: A First Data Release

Researchers across the globe are seeking to rapidly repurpose existing drugs or discover new drugs to counter the the novel coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). One promising approach is to train machine learning (ML) and artificial intelligence (AI) tools to screen large numbers of small molecules. As a contribution to that effort, we are aggregating numerous small molecules from a variety of sources, using high-performance computing (HPC) to computer diverse properties of those molecules, using the computed properties to train ML/AI models, and then using the resulting models for screening. In this first data release, we make available 23 datasets collected from community sources representing over 4.2 B molecules enriched with pre-computed: 1) molecular fingerprints to aid similarity searches, 2) 2D images of molecules to enable exploration and application of image-based deep learning methods, and 3) 2D and 3D molecular descriptors to speed development of machine learning models. This data release encompasses structural information on the 4.2 B molecules and 60 TB of pre-computed data. Future releases will expand the data to include more detailed molecular simulations, computed models, and other products.